Avid Bioservices Inc (CDMO)

[drragmop]

"That's the master phospholipid platform cancer patent."


Here's the "Field of Invention" from the patent:

"The present invention relates generally to the fields of blood vessels and tumor biology. More particularly, it embodies the surprising findings that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are accessible, stable and specific markers of tumor vasculature. The invention thus provides therapeutic constructs and conjugates that bind to aminophospholipids for use in delivering toxins and coagulants to tumor blood vessels and for inducing thrombosis and tumor regression."

I may be wrong, but IMO this patent does not include the targeting of phospholipid markers other than those found in the linings of blood vessels.

This is probably only on my mind because of the recent posts on TM-610, a protein targeting phospholipids on the walls of the actual tumor cells, and that is apparently not delivered via the bloodstream.


But I agree it is a dandy.